Responsible for redefining the global strategy in Healthcare at Imperial, building on the company infrastructure in Africa. The Market Access Healthcare business generates approx. $500 million in revenue and is growing at approx. 20%. Member of the Market Access Executive Committee . EVP with 30 years of broad, solid commercial pharmaceutical experience and a history of delivering outstanding success in both developed and Emerging Market settings. David worked for Glaxo Smith Kline (GSK) for almost 30 years in various roles with the most recent being Vice President and Head of Africa and Developing Countries Asia. As a member of the Executive Committee of ViiV Healthcare, a GSK company, delivered world leading launches of novel antiretrovirals securing commercial success for its new portfolio.